Reply to Gremese et al.: Statistical reasoning to evaluate treatment effects when data are collected with lack of design: Covid-19 experience
Proc Natl Acad Sci U S A
.
2022 Feb 15;119(7):e2103168119.
doi: 10.1073/pnas.2103168119.
Authors
Clelia Di Serio
1
2
,
Pietro Cippà
3
4
,
Alessandro Ceschi
2
4
5
6
,
Paolo Ferrari
2
3
7
Affiliations
1
University Centre of Statistics in the Biomedical Sciences, "Vita Salute San Raffaele" University, 20132 Milan, Italy; diserio.clelia@hsr.it.
2
Biomedical Faculty, Università della Svizzera Italiana, 6900 Lugano, Switzerland.
3
Department of Medicine, Division of Nephrology, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland.
4
Faculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.
5
Institute of Pharmacology and Toxicology, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland.
6
Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, 8091 Zurich, Switzerland.
7
Clinical School, University of New South Wales, Sydney, NSW 2052, Australia.
PMID:
35131936
PMCID:
PMC8851488
DOI:
10.1073/pnas.2103168119
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Humans
Problem Solving
SARS-CoV-2